Coya Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $163 | $257 | $1 | $0 |
Gross Profit | 156 | 257 | -4 | -6 |
EBITDA | -6,414,518 | -7,670 | -4,073 | -4,443 |
EBIT | -6,414,524 | -7,676 | -4,079 | -4,449 |
Net Income | -6,094,977 | -7,307 | -2,916 | -4,021 |
Net Change In Cash | 163 | 257 | 1 | 0 |
Free Cash Flow | -5,773,296 | -2,828,275 | -2,409 | -5,461 |
Cash | 29,757,328 | 35,530 | 38,339 | 31,057 |
Basic Shares | 16,724 | 16,721 | 16,357 | 15,221 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $3,554 | $6,002 | $0 | $0 |
Gross Profit | 3,554 | 6,002 | -27 | -16 |
EBITDA | -17,222 | -7,876 | -12,217 | -4,854 |
EBIT | -17,249 | -7,903 | -12,244 | -4,870 |
Net Income | -14,881 | -7,988 | -12,245 | -4,892 |
Net Change In Cash | 3,554 | 6,002 | 0 | 0 |
Free Cash Flow | -10,288 | -11,188 | -7,239 | -4,040 |
Cash | 38,339 | 32,626 | 5,933 | 4,340 |
Basic Shares | 15,239 | 10,164 | 2,590 | 6,603 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.36 |
2025-03-31 | -$0.44 |
2024-12-31 | -$0.18 |
